Leukemia
Công bố khoa học tiêu biểu
* Dữ liệu chỉ mang tính chất tham khảo
Sắp xếp:
Inhibitors targeting Bruton’s tyrosine kinase in cancers: drug development advancesAbstract Bruton’s tyrosine kinase (BTK) inhibitor is a promising novel agent that has potential efficiency in B-cell malignancies. It took approximately 20 years from target discovery to new drug approval. The first-in-class drug ibrutinib creates possibilities for an era of chemotherapy-free management of B-cell malignancies, and it is so popular that gross sales h... ... hiện toàn bộ
Leukemia - Tập 35 Số 2 - Trang 312-332 - 2021
A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification
Leukemia - Tập 21 Số 4 - Trang 668-677 - 2007
Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies
Leukemia - Tập 30 Số 11 - Trang 2142-2151 - 2016
A quantitative assay for JAK2V617F mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis
Leukemia - Tập 20 Số 6 - Trang 1055-1060 - 2006
Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells
Leukemia - Tập 29 Số 9 - Trang 1839-1846 - 2015
Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study
Leukemia - Tập 32 Số 12 - Trang 2558-2571 - 2018
Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association
Leukemia - Tập 33 Số 1 - Trang 26-36 - 2019
Isocitrate dehydrogenase mutations in myeloid malignancies
Leukemia - Tập 31 Số 2 - Trang 272-281 - 2017
Tổng số: 209
- 1
- 2
- 3
- 4
- 5
- 6
- 10